Wells Fargo & Company Epizyme, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$0.42 - $1.48 $10,245 - $36,104	-24,395 Reduced 96.01%	1,015 $1,000
Q1 2022 May 16, 2022	SELL	$1.06 - $2.68 $18,906 - $47,800	-17,836 Reduced 41.24%	25,410 $29,000
Q4 2021 Feb 14, 2022	BUY	$2.5 - $5.19 $107,817 - $223,829	43,127 Added 36241.18%	43,246 $108,000
Q3 2021 Nov 15, 2021	SELL	$4.82 - $8.46 $67 - $118	-14 Reduced 10.53%	119 $1,000
Q2 2021 Aug 16, 2021	SELL	$6.81 - $9.71 $56,046 - $79,913	-8,230 Reduced 98.41%	133 $1,000
Q1 2021 May 13, 2021	SELL	$7.45 - $12.32 $457,556 - $756,657	-61,417 Reduced 88.02%	8,363 $73,000
Q4 2020 Feb 09, 2021	BUY	$10.34 - $13.77 $259,730 - $345,888	25,119 Added 56.24%	69,780 $758,000
Q3 2020 Nov 05, 2020	SELL	$11.73 - $16.25 $204,160 - $282,831	-17,405 Reduced 28.04%	44,661 $533,000
Q2 2020 Aug 13, 2020	BUY	$13.68 - $20.46 $272,615 - $407,726	19,928 Added 47.29%	62,066 $997,000
Q1 2020 May 14, 2020	BUY	$14.83 - $26.72 $624,906 - $1.13 Million	42,138 New	42,138 $654,000

About Epizyme, Inc.

Ticker EPZM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 168,364,992
Market Cap $247M

More about EPZM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.